Category: Pharmaceuticals
Global Pharmaceuticals
-
Global Chlorhexidine Gluconate Product for Patient Skin Antisepsis Market Report, History and Forecast 2019-2030
... reach $ 780.46 million by 2030, at a CAGR of 3.64% during the forecast period of 2024 through 2030. North American market for Chlorhexidine Gluconate Product for Patient Skin Antisepsis was valued at $ 217.01 ... Read More
-
Impact of Covid-19 on Pharmaceuticals Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2024-2032
... of Covid-19 on the pharmaceuticals market size was valued at USD 1,494.67 billion in 2021, and the market is now projected to grow from USD 1,585.05 billion in 2022 to USD 2,401.22 billion by 2029, ... Read More
-
Algae Products Market Global Forecast Report by Type (Lipids, Carrageenan, Carotenoids, Algal Protein, Alginate, Others), Source (Brown Algae, Blue-Green Algae, Red Algae, Green Algae), Form (Solid, Liquid), Application (Food and Beverages, Nutraceuticals and Dietary Supplements, Personal Care, Feed, Pharmaceuticals, Chemicals, Others), Countries and Company Analysis 2024-2032
... Personal Care, Feed, Pharmaceuticals, Chemicals, Others), Countries and Company Analysis 2024-2032 Algae Products Market Size The Algae Products market is expected to reach US$ 4.23 Billion in 2023 to US$ 7.35 Billion by 2032, with ... Read More
-
Global Biosimilars Market (2nd Edition)
... has experienced significant growth, owing to its improved effectiveness in managing chronic diseases. However, the high costs associated with biologics pose considerable economic and healthcare challenges. As the demand for biologics continues to increase, developers ... Read More
-
Biopreservation Market Report Global Forecast By Product (Equipment, Media, Laboratory Information Management System (LIMS)), Application (Regenerative Medicine, Biobanking, Drug Discovery), Countries and Company Analysis (2025-2033)
... US$ 5.44 billion in 2024 and to reach US$ 24.51 billion by 2033, with a CAGR of 18.20% during 2025-2033. The main driving factors behind this growth include the rising demand for personalized medicine, R&D ... Read More
-
LED Video Walls
... by 2030, growing at a CAGR of 6.9% over the analysis period 2023-2030. Indoor Deployment, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach US$2.0 Billion by ... Read More
-
Nail Care
... at a CAGR of 2.5% over the analysis period 2023-2030. Nail Polishes, one of the segments analyzed in the report, is expected to record a 2.8% CAGR and reach US$8.3 Billion by the end of ... Read More
-
Patient Monitoring Devices
... by 2030, growing at a CAGR of 7.4% over the analysis period 2023-2030. Blood Glucose Monitoring Devices, one of the segments analyzed in the report, is expected to record a 7.8% CAGR and reach US$23.2 ... Read More
-
Probiotics Dietary Supplements
... by 2030, growing at a CAGR of 5.8% over the analysis period 2023-2030. Capsules Form, one of the segments analyzed in the report, is expected to record a 5.6% CAGR and reach US$4.2 Billion by ... Read More
-
Restorative Dentistry
... at a CAGR of 8.3% over the analysis period 2023-2030. Restorative Materials, one of the segments analyzed in the report, is expected to record a 9.4% CAGR and reach US$19.4 Billion by the end of ... Read More
-
Veterinary Pain Management
... by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Pain Management Drugs, one of the segments analyzed in the report, is expected to record a 8.0% CAGR and reach US$2.1 Billion ... Read More
-
Oncology Based In-Vivo CRO
... reach US$2.5 Billion by 2030, growing at a CAGR of 7.0% over the analysis period 2023-2030. Solid Tumors Indication, one of the segments analyzed in the report, is expected to record a 6.9% CAGR and ... Read More
-
Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
... released a research report titled “Global Epilepsy Therapeutics Market (2024 Edition)” which provides an analysis of the Global Epilepsy Therapeutics industry in terms of market segmentation By Generation (First Generation, Second Generation, Third Generation), By ... Read More
-
Orphan Drugs
... at a CAGR of 11.9% over the analysis period 2023-2030. Biologic Drugs, one of the segments analyzed in the report, is expected to record a 12.7% CAGR and reach US$286.3 Billion by the end of ... Read More
-
Pesticide Inert Ingredients
... by 2030, growing at a CAGR of 6.1% over the analysis period 2023-2030. Emulsifiers, one of the segments analyzed in the report, is expected to record a 7.0% CAGR and reach US$3.3 Billion by the ... Read More
-
Brain Computer Interface
... by 2030, growing at a CAGR of 10.3% over the analysis period 2023-2030. Invasive BCI, one of the segments analyzed in the report, is expected to record a 11.6% CAGR and reach US$1.5 Billion by ... Read More
-
Microwave Ablation
... at a CAGR of 13.0% over the analysis period 2023-2030. Liver Cancer Application, one of the segments analyzed in the report, is expected to record a 14.9% CAGR and reach US$215.5 Million by the end ... Read More
-
Sodium Alginate
... at a CAGR of 4.9% over the analysis period 2023-2030. Stabilizers Application, one of the segments analyzed in the report, is expected to record a 5.2% CAGR and reach US$137.4 Million by the end of ... Read More
-
Venturi Masks
... at a CAGR of 11.5% over the analysis period 2023-2030. COPD Application, one of the segments analyzed in the report, is expected to record a 13.5% CAGR and reach US$2.9 Billion by the end of ... Read More
-
Insulin Pens
... at a CAGR of 7.1% over the analysis period 2023-2030. Disposable Insulin Pens, one of the segments analyzed in the report, is expected to record a 7.7% CAGR and reach US$11.6 Billion by the end ... Read More
-
Soft Tissue Repair
... by 2030, growing at a CAGR of 6.0% over the analysis period 2023-2030. Fixation Products, one of the segments analyzed in the report, is expected to record a 6.5% CAGR and reach US$19.6 Billion by ... Read More
-
Diabetic Shoes
... at a CAGR of 8.1% over the analysis period 2023-2030. Online Distribution Channel, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$10.6 Billion by the end ... Read More
-
Desmopressin
... of 5.5% over the analysis period 2023-2030. Injectable Solution, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$866.1 Million by the end of the analysis period. ... Read More
-
Natural Antioxidants
... at a CAGR of 5.9% over the analysis period 2023-2030. Vitamin C, one of the segments analyzed in the report, is expected to record a 6.1% CAGR and reach US$1.4 Billion by the end of ... Read More
-
Acne Drugs
... at a CAGR of 6.8% over the analysis period 2023-2030. Inflammatory Drugs, one of the segments analyzed in the report, is expected to record a 7.4% CAGR and reach US$9.6 Billion by the end of ... Read More
Research Assistance
